M&A Deal Summary |
|
|---|---|
| Date | 2015-12-07 |
| Target | PMG Research |
| Sector | Life Science |
| Buyer(s) | ICON |
| Sellers(s) | Frontier Growth |
| Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1990 |
| Sector | Life Science |
| Employees | 41,100 |
| Revenue | 8.1B USD (2023) |
ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support clinical development – from compound selection to Phase I-IV clinical studies. ICON was founded in 1990 and is based in Dublin, Ireland.
| DEAL STATS | # |
|---|---|
| Overall | 22 of 29 |
| Sector (Life Science) | 12 of 16 |
| Type (Add-on Acquisition) | 18 of 25 |
| State (North Carolina) | 1 of 2 |
| Country (United States) | 14 of 18 |
| Year (2015) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-02-02 |
MediMedia Pharma Solutions
Yardley, Pennsylvania, United States MediaMedia Pharma Solutions is a combination of MediMedia Managed Markets and Complete HealthCare Communications. The company is a provider of strategic payer-validated market access solutions for the biopharmaceutical and medical device industries. |
Buy | $120M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-06-30 |
Clinical Research Management
Agawam, Massachusetts, United States Clinical Research Management, Inc. is a provider of full service and functional research solutions to a broad range of US government agencies. Their extensive expertise extends across basic and applied research, infectious diseases, vaccines development and testing and the response to bio-threats. They have worked in collaboration with government and commercial customers to respond to the threat of global viral epidemics. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1999 |
| PE ASSETS | 1.0B USD |
| Size | Middle-Market |
| Type | Sector Focused |
Frontier Capital LLC is a private investment firm that provides expansion capital to high-growth 'technology-enabled' business service companies generating revenues $8-$30 million. Frontier targets companies that utilize technology, an innovative business process, or a unique expertise to deliver a differentiated service to customers. Frontier typically invests throughout the Southeast and Mid-Atlantic regions of the US and looks to commit $10 to $50 million of equity capital per transaction. Investment proceeds are generally used for growth initiatives, acquisitions, or to provide shareholder liquidity. Frontier Capital was formed in 1999 and is based in Charlotte, North Carolina.
| DEAL STATS | # |
|---|---|
| Overall | 22 of 38 |
| Sector (Life Science) | 2 of 2 |
| Type (Add-on Acquisition) | 13 of 23 |
| State (North Carolina) | 6 of 6 |
| Country (United States) | 22 of 36 |
| Year (2015) | 3 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-12-01 |
iMapData
McLean, Vermont, United States iMapData, Inc. is a data visualization and analysis company. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-05-11 |
Zephyr
Newark, California, United States D Software, Inc. is a provider of software test management solutions. Zephyr provides more than 8,500 customers in over 100 countries with innovative applications, seamless integrations and unparalleled, real-time visibility into the quality and status of their software development projects. D Software, Inc. was founded in 2007 and is based in Newark, California. |
Buy | - |
